Analysis and Consideration of Legal Issues Related to Stem Cell Therapy

Abstract

Stem cell therapy has gained momentum in recent years and has positively and innovatively impacted the biomedical field. This paper uses a comprehensive literature analysis and comparative methodology to compare the differences in the development and regulatory systems of stem cell therapies in the UK and China through the available references. The legal framework for stem cell therapies is more complete in the UK, and the government has invested in a regulatory system that promotes research and development. By contrast, China has had problems with surveillance confusion in the past. In recent years, it has worked to standardize the development of therapies and strengthen the regulatory system. While both countries are improving their censorship, some challenges remain. Based on the challenges analyzed, this paper intends to provide suggestions to those involved in stem cell therapies to develop better in the future.